Sanofi v. Sun Pharma Global FZE
1:15-cv-01208
Overview
Parties
Defendant
Sanofi Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Sun Pharmaceutical Industries, Ltd. Operating Company
Represented By
4 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Bayard, P.A.
Bayard, P.A., 600 N. King Street
Gould & Ratner LLP
222 N. LaSalle Street, Suite 800
Sun Pharma Global FZE Operating Company
Represented By
9 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 655-5000
Bayard, P.A.
Bayard, P.A., 600 N. King Street
Gould & Ratner LLP
222 N. LaSalle Street, Suite 800
Sanofi-Aventis U.S. LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 9,107,900 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2015032818 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2017027393 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2019004649 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2021026793 | US Continuation / Sibling | View Official Patent → |
| 🇫🇷 France | FR 0802127 A | France Counterpart | View Official Patent → |
| 🇫🇷 France | FR 2930148 A1 | France Counterpart | View Official Patent → |
| 🇺🇸 United States | US 4,599,508 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,025,708 P | US Continuation / Sibling | View Official Patent → |
| 🇫🇷 France | FR 0803208 | France Counterpart | View Official Patent → |
| 🇺🇸 United States | US 15,162,209 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 15,161,109 P | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 9,290,098 | European Counterpart (EP) | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 9,290,095 | European Counterpart (EP) | View Official Patent → |
| 🇺🇸 United States | US 15,995,609 P | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9107900
Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality
|
Filed: 2013-03-19
Issued: 2015-08-18
|
Active (6.3 yrs remaining)
Expires: 2033-03-19
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings